These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31511185)

  • 1. Yes, Improve the US Value Frameworks, But Recognize They Are Already in Prime Time.
    Neumann PJ
    Value Health; 2019 Sep; 22(9):975-976. PubMed ID: 31511185
    [No Abstract]   [Full Text] [Related]  

  • 2. As Value Assessment Frameworks Evolve, Are They Finally Ready for Prime Time?
    Dubois RW; Westrich K
    Value Health; 2019 Sep; 22(9):977-980. PubMed ID: 31511186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ISPOR's Initiative on US Value Assessment Frameworks: The Use of Cost-Effectiveness Research in Decision Making among US Insurers.
    Solow B; Pezalla EJ
    Value Health; 2018 Feb; 21(2):166-168. PubMed ID: 29477395
    [No Abstract]   [Full Text] [Related]  

  • 4. ISPOR's Initiative on US Value Assessment Frameworks: An Industry Perspective.
    Burkholder R; Dougherty JS; Neves LA
    Value Health; 2018 Feb; 21(2):173-175. PubMed ID: 29477398
    [No Abstract]   [Full Text] [Related]  

  • 5. ISPOR's Initiative on US Value Assessment Frameworks: Seeking a Role for Health Economics.
    Sculpher M
    Value Health; 2018 Feb; 21(2):171-172. PubMed ID: 29477397
    [No Abstract]   [Full Text] [Related]  

  • 6. ISPOR's Initiative on US Value Assessment Frameworks: A Missed Opportunity for ISPOR and Patients.
    Perfetto EM
    Value Health; 2018 Feb; 21(2):169-170. PubMed ID: 29477396
    [No Abstract]   [Full Text] [Related]  

  • 7. Objectives, Budgets, Thresholds, and Opportunity Costs-A Health Economics Approach: An ISPOR Special Task Force Report [4].
    Danzon PM; Drummond MF; Towse A; Pauly MV
    Value Health; 2018 Feb; 21(2):140-145. PubMed ID: 29477391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Health Economics Approach to US Value Assessment Frameworks-Introduction: An ISPOR Special Task Force Report [1].
    Neumann PJ; Willke RJ; Garrison LP
    Value Health; 2018 Feb; 21(2):119-123. PubMed ID: 29477388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to Aggregation and Decision Making-A Health Economics Approach: An ISPOR Special Task Force Report [5].
    Phelps CE; Lakdawalla DN; Basu A; Drummond MF; Towse A; Danzon PM
    Value Health; 2018 Feb; 21(2):146-154. PubMed ID: 29477392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7].
    Garrison LP; Neumann PJ; Willke RJ; Basu A; Danzon PM; Doshi JA; Drummond MF; Lakdawalla DN; Pauly MV; Phelps CE; Ramsey SD; Towse A; Weinstein MC
    Value Health; 2018 Feb; 21(2):161-165. PubMed ID: 29477394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Health Economics Approach to US Value Frameworks: Serving the Needs of Decision Making.
    Norman R; Chalkidou K; Culyer AJ
    Value Health; 2018 Feb; 21(2):117-118. PubMed ID: 29477387
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessing value in health care programs.
    Volpp KG; Loewenstein G; Asch DA
    JAMA; 2012 May; 307(20):2153-4. PubMed ID: 22618919
    [No Abstract]   [Full Text] [Related]  

  • 13. Review of Recent US Value Frameworks-A Health Economics Approach: An ISPOR Special Task Force Report [6].
    Willke RJ; Neumann PJ; Garrison LP; Ramsey SD
    Value Health; 2018 Feb; 21(2):155-160. PubMed ID: 29477393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2].
    Garrison LP; Pauly MV; Willke RJ; Neumann PJ
    Value Health; 2018 Feb; 21(2):124-130. PubMed ID: 29477389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improving the transparency and credibility of cost-effectiveness analysis of healthcare interventions].
    Catalá-López F; Ridao M
    Rev Esp Salud Publica; 2016 Mar; 90():E1. PubMed ID: 27063024
    [No Abstract]   [Full Text] [Related]  

  • 16. One size does not always fit all in value assessment.
    Basu A; Grieve R; Pritchard D; Stevens W
    Am J Manag Care; 2019 Nov; 25(11):540-542. PubMed ID: 31747231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ICER Value Framework: Integrating Cost Effectiveness and Affordability in the Assessment of Health Care Value.
    Pearson SD
    Value Health; 2018 Mar; 21(3):258-265. PubMed ID: 29566831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic principles of cost-effectiveness analysis.
    Hillner BE
    Med Sect Proc; 1987; ():45-53. PubMed ID: 3133653
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-benefit and cost-effective analysis in surgery.
    Barnes BA
    Surg Clin North Am; 1982 Aug; 62(4):737-49. PubMed ID: 6810483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should cost considerations be included in medical decisions? Yes.
    Guidet B; Beale R
    Intensive Care Med; 2015 Oct; 41(10):1838-40. PubMed ID: 26215681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.